Moreover, a recent study demonstrated that mutant KRAS CRC displayed low infiltration with CD4+ T-cells and CD4+/FOXP3+ Tregs but were highly infiltrated with myeloid-derived suppressor cells (MDSCs). The gene discussed is KRAS; the disease is colorectal carcinoma.